- Home
- TRUG vs SNOA Comparison
TRUG vs SNOA Comparison
Compare TRUG & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- SNOA
- Stock Information
- Founded
- TRUG 1983
- SNOA 1999
- Country
- TRUG United States
- SNOA United States
- Employees
- TRUG N/A
- SNOA N/A
- Industry
- TRUG
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- TRUG
- SNOA Health Care
- Exchange
- TRUG NYSE
- SNOA Nasdaq
- Market Cap
- TRUG 8.4M
- SNOA 6.4M
- IPO Year
- TRUG N/A
- SNOA 2007
- Fundamental
- Price
- TRUG $0.24
- SNOA $3.47
- Analyst Decision
- TRUG Strong Buy
- SNOA
- Analyst Count
- TRUG 1
- SNOA 0
- Target Price
- TRUG $2.00
- SNOA N/A
- AVG Volume (30 Days)
- TRUG 8.4M
- SNOA 70.1K
- Earning Date
- TRUG 05-15-2025
- SNOA 06-16-2025
- Dividend Yield
- TRUG N/A
- SNOA N/A
- EPS Growth
- TRUG N/A
- SNOA N/A
- EPS
- TRUG N/A
- SNOA N/A
- Revenue
- TRUG $22,236,072.00
- SNOA $13,973,000.00
- Revenue This Year
- TRUG $24.05
- SNOA $23.89
- Revenue Next Year
- TRUG $31.65
- SNOA $25.45
- P/E Ratio
- TRUG N/A
- SNOA N/A
- Revenue Growth
- TRUG 8.40
- SNOA 13.51
- 52 Week Low
- TRUG $0.17
- SNOA $1.75
- 52 Week High
- TRUG $1.52
- SNOA $9.37
- Technical
- Relative Strength Index (RSI)
- TRUG 46.22
- SNOA 59.16
- Support Level
- TRUG $0.20
- SNOA $3.05
- Resistance Level
- TRUG $0.42
- SNOA $3.41
- Average True Range (ATR)
- TRUG 0.05
- SNOA 0.20
- MACD
- TRUG 0.00
- SNOA -0.00
- Stochastic Oscillator
- TRUG 25.14
- SNOA 79.31
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.